Luminex Wraps Up RBM Spinoff; Chandler Moves On | GenomeWeb

NEW YORK, Sept. 9 - Luminex today said it has finished folding its Rules-Based Medicine project into a newly created company. The deal, announced last month, frees the Texas-based company to concentrate on selling its instruments and bead technology.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.